Condition: Tricuspid Valve Regurgitation · Sponsor: inQB8 Medical Technologies, LLC
Prospective, multi-center study to assess safety and performance of the inQB8 MonarQ Tricuspid Valve Replacement System.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Cedars-Sinai Medical Center | Los Angeles, California, United States | Recruiting |
| Los Robles Hosptial and Medical Center | Thousand Oaks, California, United States | Recruiting |
| Piedmont Atlanta Hospital | Atlanta, Georgia, United States | Recruiting |
| North Shore University Hospital | Manhasset, New York, United States | Recruiting |
| Penn Presbyterian Medical Center | Philadelphia, Pennsylvania, United States | Recruiting |
| Baylor Heart Hospital | Plano, Texas, United States | Recruiting |
| AZ Sint-Jan Brugge AV | Bruges, Belgium | Recruiting |
| St. Michael's Hospital | Toronto, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06611579